| - GRCh37:
- ChrMT:5514
- GRCh38:
- ChrMT:5514
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5515
- GRCh38:
- ChrMT:5515
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5516
- GRCh38:
- ChrMT:5516
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5521
- GRCh38:
- ChrMT:5521
| MT-TW | | Mitochondrial disease | Likely pathogenic (Oct 3, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:5523
- GRCh38:
- ChrMT:5523
| MT-TW | | Leigh syndrome | not provided | no assertion provided |
| - GRCh37:
- ChrMT:5524
- GRCh38:
- ChrMT:5524
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5527
- GRCh38:
- ChrMT:5527
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5528
- GRCh38:
- ChrMT:5528
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5530
- GRCh38:
- ChrMT:5530
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5532
- GRCh38:
- ChrMT:5532
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5536-5537
- GRCh38:
- ChrMT:5536-5537
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5537-5538
- GRCh38:
- ChrMT:5537-5538
| MT-TW | | not provided | Pathogenic (Oct 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5538
- GRCh38:
- ChrMT:5538
| MT-TW | | Mitochondrial disease | Uncertain significance (Oct 26, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:5539
- GRCh38:
- ChrMT:5539
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5539
- GRCh38:
- ChrMT:5539
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5540
- GRCh38:
- ChrMT:5540
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:5542
- GRCh38:
- ChrMT:5542
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5543
- GRCh38:
- ChrMT:5543
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:5544
- GRCh38:
- ChrMT:5544
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5545
- GRCh38:
- ChrMT:5545
| MT-TW | | Encephalocardiomyopathy, mitochondrial | Pathogenic (Jun 15, 2008) | no assertion criteria provided |
| - GRCh37:
- ChrMT:5549
- GRCh38:
- ChrMT:5549
| MT-TW | | Mitochondrial encephalopathy | Pathogenic (Mar 1, 1995) | no assertion criteria provided |
| - GRCh37:
- ChrMT:5550
- GRCh38:
- ChrMT:5550
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5553
- GRCh38:
- ChrMT:5553
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5553
- GRCh38:
- ChrMT:5553
| MT-TW | | not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign/Likely benign (Jul 12, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:5554
- GRCh38:
- ChrMT:5554
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5556
- GRCh38:
- ChrMT:5556
| MT-TW | | Mitochondrial encephalomyopathy | Pathogenic (Mar 1, 2010) | no assertion criteria provided |
| - GRCh37:
- ChrMT:5557
- GRCh38:
- ChrMT:5557
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5558
- GRCh38:
- ChrMT:5558
| MT-TW | | Mitochondrial disease | Uncertain significance (Dec 10, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:5559
- GRCh38:
- ChrMT:5559
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5560
- GRCh38:
- ChrMT:5560
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5561
- GRCh38:
- ChrMT:5561
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5563
- GRCh38:
- ChrMT:5563
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5566
- GRCh38:
- ChrMT:5566
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5567
- GRCh38:
- ChrMT:5567
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5568
- GRCh38:
- ChrMT:5568
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5573
- GRCh38:
- ChrMT:5573
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5575
- GRCh38:
- ChrMT:5575
| MT-TW | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |